Notably, the CD44+CD24+ESA+ cells represent a particularly small cell fraction in human pancreatic adenocarcinomas, as this subset comprises less than 1% of the pancreatic cancer cell population [149]. The gene discussed is CD24; the disease is pancreatic neoplasm.